Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Southern Anesthesia and Surgical (SAS) was a leading US distributor of pharmaceuticals (including controlled and non-controlled substances), sedation-related dental drugs, and surgical supplies for oral health providers, specifically oral surgeons, periodontists, and dental anesthesiologists. The company did not engage in clinical drug development. In 2022, SAS merged with ACE Surgical Supply to form ACE SOUTHERN under Henry Schein, continuing to serve the oral health market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Southern Anesthesia and Surgical.